• Cost-Effectiveness Of Ceritinib In Previously Treated Patients With Crizotinib In Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small Cell Lung Cancer In Canada

    Nov 1, 2015, 00:00

  • Patients’ Preferences Regarding The Setting Of Electronic Patient-Reported Outcome Assessments

    Nov 1, 2015, 00:00

  • Characterisitcs and Drug Utilization among Treated Chronic Hepatitis C Virus (Chc) Patients with and without Chronic Kidney Disease (Ckd) in the Us

    Nov 1, 2015, 00:00

  • Instrumentos Para la Incorporacion de la Evaluacion Economica, el Impacto Presupuestario y Los Esquemas de Pago por Resultados en el Servicio Catalán de Salud (España)

    Nov 1, 2015, 00:00

  • Comparisons of Factor Consumption for Routine Prophylaxis And Bleeding During Episodic Therapy With Recombinant Factor Viii Fc Fusion Protein and Conventional Recombinant Factor Viii

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness of Biologics for The Treatment of Inflammatory Bowel Diseases- A Systematic Review

    Nov 1, 2015, 00:00

  • Costo De Hipertension Arterial En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00

  • Estimating the Lifetime Indirect Cost of Childhood Overweight and Obesity- A Markov Modelling Study

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Dolutegravir/Abacavir/Lamivudine (Dtg/Abc/3tc) as a Single Tablet Treatment of Naïve Hiv Infected Patientss

    Nov 1, 2015, 00:00

  • Taking Medication Safely- Implementing And Developing A Medication Review Program In German Community Pharmacies Over 4 Years

    Nov 1, 2015, 00:00

  • Financial Impact of Not Prescribing “By The Book”- Art and Sustainability of Seguro Popular

    Nov 1, 2015, 00:00

  • Prevalence of Acne Vulgaris in Europe and Impact of Lifestyle Factors

    Nov 1, 2015, 00:00

  • Trends in Prevalence and Incidence Rates of Type 2 Diabetes Mellitus in Medicare Population

    Nov 1, 2015, 00:00

  • Patient-Reported Outcomes in Studies Published in 2014- which Tools have been most Commonly Used in Studies of Musculoskeletal Disorders?

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Capnography Monitoring During Gastrointestinal Endoscopy Targeting Moderate Sedation

    Nov 1, 2015, 00:00

  • Impact of Pain Severity on Patient-Reported Outcomes of Individuals With Chronic Lower Back Pain In Japan

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Ceritinib In The Treatment Of Previously Treated Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small Cell Lung Cancer In The United Kingdom

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Nexplanon® (Etonogestrel Implant) Compared to other Reimbursed Contraceptive Methods in France Based on Real Life Data

    Nov 1, 2015, 00:00

  • Changes Of Sick-Pay Expenditures In Hungary Between 2005-2013

    Nov 1, 2015, 00:00

  • Relationship between Glycaemic Burden and Micro- and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus- A real-world study in the Pharmo Database Network

    Nov 1, 2015, 00:00

  • Time Ratios Or Hazard Ratios- Accelerating Toward A New Approach?

    Nov 1, 2015, 00:00

  • Systematic Review on Use of Economic Evidence in Clinical Guidelines

    Nov 1, 2015, 00:00

  • Assessing The Efficiency Of The Long-Term Care Hospital Units In Hungary Between 2006 And 2013

    Nov 1, 2015, 00:00

  • Improvements in Patient-Reported outcomes Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis- Results from the C-Early Ra ...

    Nov 1, 2015, 00:00

  • Efficacy And Safety of Antidiabetic Drugs Available on Brazilian Public Health System (Sus) – Regular Insulin, Nph Insulin, Metformin, Glibenclamide And Gliclazide – In Treatment of Type 2 Diabetes (T2dm) - Systematic Review And Meta-Analys ...

    Nov 1, 2015, 00:00

  • Exploring Cost-Effectiveness Heterogeneity By State- Using State-Level Vs. National Disease Incidence In Newborn Screening (Nbs) Cost-Effectiveness Analysis of Congenital Adrenal Hyperplasia (Cah)

    Nov 1, 2015, 00:00

  • Economic Impact of The End of The Market Exclusivity for Orphan Drugs

    Nov 1, 2015, 00:00

  • A Budget Impact Model Estimating the Financial Impact of Increased Use of Generic Bortezomib Intravenous (Iv) in the Treatment of Relapsed/Refractory Multiple Myeloma (Mm) in Venezuela

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Pegfilgrastim As Prophylaxis For Febrile Neutropenia In Patients With Solid Tumors Or Lymphoma Receiving Chemotherapy In Mexico

    Nov 1, 2015, 00:00

  • Adherence, Healthcare Resource Use (Hru) And Costs- A Comparison Of Single-Tablet Regimen (Str) Versus Multi-Tablet Regimen (Mtr) Containing Fixed Dose Combination (Fdc) Regimens

    Nov 1, 2015, 00:00

  • Ledipasvir / Sofosbuvir for The Treatment of Chronic Hepatitis C- A Cost-Effectiveness Analysis Across Different Genotype 1 Clinical Subgroups

    Nov 1, 2015, 00:00

  • TREATMENT STRATEGIES FOR ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA- A META-ANALYSIS AND INDIRECT TREATMENT COMPARISON

    Nov 1, 2015, 00:00

  • From Law To Reality- Measuring Time-To-Access Of Conitec Approved Drugs In Brazilian Public Health Care System (Sus) In The State Of Paraná

    Nov 1, 2015, 00:00

  • Comparative Cost-Effectiveness of Drugs in Early Versus Late Stages of Cancer; Review of the Literature and a Case Study in Breast Cancer

    Nov 1, 2015, 00:00

  • Prevalence and Perception of Use of Non-Prescription Medicines among Medical Student in Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Association of Adverse Events And Health Service Usage With Tapentadol Prolonged-Release Treatment Compared With Morphine Controlled-Release (Cr) And Oxycodone Cr- A Uk Primary Care Observational Study

    Nov 1, 2015, 00:00

  • Quantifying Costs of Medical Personnel Involved with Radiation therapy Using Administrative Databases

    Nov 1, 2015, 00:00

  • Costo En Salud Del Programa Presupuestal De Salud Materno Neonatal Para Reducir La Tasa De Mortalidad Materna Y Neonatal En El Perú, 2009 - 2014

    Nov 1, 2015, 00:00

  • Outcomes Used In Clinical Studies In Adult Hematoncology- Ten Years Of Publications In Pubmed

    Nov 1, 2015, 00:00

  • Knowledge On Breast Cancer Among Women In Tolna And Baranya Counties, Hungary

    Nov 1, 2015, 00:00

  • Panitumumab + Mfolfox6 Versus Bevacizumab + Mfolfox6 As First-Line Treatment of Wild-Type Ras Metastatic Colorectal Cancer- A Cost-Effectiveness Analysis from the Brazilian Private Healthcare System Perspective

    Nov 1, 2015, 00:00

  • General Assessment Of Unlicensed Antineoplastic And Immunomodulating Medicine Usage In Turkey

    Nov 1, 2015, 00:00

  • Health System Research Opportunities for Assessment of The National Health Care System

    Nov 1, 2015, 00:00

  • The Relationship Between Glucose-Lowering Medications, Adherence, and Outcomes in Patients with Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Abatacept Compared to Adalimumab In Italy Based on A Head-To-Head Outcomes Study In Rheumatoid Arthritis

    Nov 1, 2015, 00:00

  • Impacto Presupuestario De Incorporar Linagliptina Para El Tratamiento De La Diabetes En Argentina

    Nov 1, 2015, 00:00

  • The Impact of the increasing Penetration of on-Patent Medicines on the Greek Pharmaceutical Market

    Nov 1, 2015, 00:00

  • The Economic Impact of an Hypothetical Rx-To-otc Switch in Spain

    Nov 1, 2015, 00:00

  • Quality Assessment of Diagnostic Studies- Study Designs Leading to High and Low Risk of Bias

    Nov 1, 2015, 00:00

  • Linguistic Validation of The Emphasis-10 Questionnaire- A Patient-Reported Outcome Instrument For Assessing Qol In Pulmonary Hypertension (Ph)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Pramipexole Extended Release Monotherapy In Early Parkinson`S Disease

    Nov 1, 2015, 00:00

  • Knowledge Regarding Harmful Effects of Child Vaccination and Reasons of Non-Vaccination Among Married Population of Mastung, Pakistan

    Nov 1, 2015, 00:00

  • The Burden of Cancer in Jamaica

    Nov 1, 2015, 00:00

  • Reviewing The Cost-Effectiveness of Chemotherapy and Targeted Therapy for Metastatic Breast Cancer

    Nov 1, 2015, 00:00

  • Comparison of current and preferred status of hta implementation in central and eastern europen countries

    Nov 1, 2015, 00:00

  • Telerehabilitation after Total Knee Replacement- Preliminary Cost-Effectiveness Analysis of an Innovative Device

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Apremilast for The Treatment of Psoriatic Arthritis Patients In Spain

    Nov 1, 2015, 00:00

  • Mortality Trends In Cancers- A New Model To Visualise The Contribution Of Specific Diseases, Cohorts And Coding Changes To Overall Mortality Improvement

    Nov 1, 2015, 00:00

  • The Long-Term Cost-Effectiveness of Twice-Daily Exenatide with Insulin Glargine Versus Once-Daily Liraglutide with Insuline Detemir in Adult Patients with Type 2 Diabetes in Russia

    Nov 1, 2015, 00:00

  • Economic Impact of Treating Chinese Postmenopausal Women with 17-ß-Estradiol Combined Hormone Replacment Therapy (Hrt) Compared with the Alternative Practices

    Nov 1, 2015, 00:00

  • Capturing Quality of Life (Qol) Data in Rare Indications- Case Study in Radioiodine-Refractory Thyroid Cancer (Rr-Dtc)

    Nov 1, 2015, 00:00

  • Disutilities Associated with Central Nervous System (Cns) Side Effects of Antiretroviral Therapy (Art) in Hiv

    Nov 1, 2015, 00:00

  • Optimizacion De La Quimioterapia En El Cáncer Epidermoide De Pulmon Avanzado, Antimetabolitos O Taxanos?

    Nov 1, 2015, 00:00

  • Operational Validation of Health Economic Decision Analytic Models

    Nov 1, 2015, 00:00

  • Epidemiology And Treatment Of Soft Tissue Sarcoma In The Eu5

    Nov 1, 2015, 00:00

  • Economic, Public Health, And Humanistic Impact of a Quadrivalent Human Papillomavirus (Hpv6/11/16/18) Vaccination Program For Females And Males Age 9-11 Years in Mexico

    Nov 1, 2015, 00:00

  • Clinical Evaluation Of Kanakasava And Swasanandam Gulika In Bronchial Asthma

    Nov 1, 2015, 00:00

  • Eficacia De Docetaxel En Pacientes Con Cáncer De Prostata Resistente A Castraci”N En Primera Línea De Tratamiento

    Nov 1, 2015, 00:00

  • Reforming Drug Pricing and Patient Access Systems to Support Universal Coverage In Developing Countries

    Nov 1, 2015, 00:00

  • Costo De Enfermedades Mentales Prevalentes En Perú

    Nov 1, 2015, 00:00

  • Descriptive Evaluation of Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Ovarian Cancer

    Nov 1, 2015, 00:00

  • Oncologist Support for American Society of Clinical Oncology (Asco) Consolidated Payments for Cancer Care Management in the United States (Us)

    Nov 1, 2015, 00:00

  • Assessment Of Serious Adverse Reactions Among Patients On Tyrosine Kinase Inhibitors- Identification Of Significant Signals For Gastrointestinal Hemorrhage And Pulmonary Reactions

    Nov 1, 2015, 00:00

  • How Does The Additional Benefit Extent of Orphan Drugs Impact Price Negotiations In The German Outpatient Sector?

    Nov 1, 2015, 00:00

  • The Impact of Baseline Hba1c and Hba1c Trajectories on Time to Therapy Escalation In Type 2 Diabetes Mellitus

    Nov 1, 2015, 00:00

  • Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the philippines

    Nov 1, 2015, 00:00

  • Rasch Analysis In The Development of A Specific Health-Related Quality of Life Questionnaire for Hypoglycemic Events In Diabetic Patients- The Qolhypo Questionnaire

    Nov 1, 2015, 00:00

  • Impact of Weight Loss on Patient-Reported Outcomes In The Scale Obesity and Prediabetes Trial of Liraglutide 3.0 Mg As Adjunct to A Diet and Exercise (DE) Programme

    Nov 1, 2015, 00:00

  • Effect of The Reorganization of The Intensive Care Units System In Hungary

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Four Schemes For Screening And Diagnosis Of Type 2 Diabetes In Adults In Colombia

    Nov 1, 2015, 00:00

  • What Factors Influence Survival In Stroke- Turkey Case

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Combined Treatment With Alteplase (Rt-Pa) And Cerebrolysin In Acute Ischemic Hemispheric Stroke In Austria

    Nov 1, 2015, 00:00

  • Comparison Of Epidermal Growth Factor Receptor (Egfr) Tested And Not-Tested Metastatic Non-Small Cell Lung Cancer (Mnsclc) Patient Cohorts In Europe

    Nov 1, 2015, 00:00

  • Introduction of New Combination Therapy for Treatment of Experienced Hcv Gt1 Patients- Budget Impact Analysis, The Croatian Perspective

    Nov 1, 2015, 00:00

  • Telerehabilitation after Total Knee Replacement- Preliminary Cost-Utility Analysis of an Innovative Device

    Nov 1, 2015, 00:00

  • Cost Of Smoking In Asia

    Nov 1, 2015, 00:00

  • A Web-Based Survey to Investigate the Extent of Awareness and Understanding for Biosimilar among Japanese Physicians and Pharmacists

    Nov 1, 2015, 00:00

  • Prevalence And Reasons For Nonadherence To Aromatase Inhibitors In An Outpatient Oncology Clinic

    Nov 1, 2015, 00:00

  • The Quality Of Life Of Parents Of Pediatric Kidney Transplantation Patients

    Nov 1, 2015, 00:00

  • Heatlh Care Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis Taking Once Daily Teriflunomide Tablets in the United States

    Nov 1, 2015, 00:00

  • Assessing the Gap Between Evidence Based Indications for Radiotherapy and Actual Practice in European Countries

    Nov 1, 2015, 00:00

  • Incorporacion de Los Resultados de La Evaluacion Economica en Las Recomendaciones de Las Guías de Práctica Clínica en Colombia

    Nov 1, 2015, 00:00

  • Prevention of Fragility Fractures in Osteoporotic Patients- Can the Secondary Therapy Help Contain Costs for Admissions? A Retrospective, Observational Case Control Study Based on Asl Pavia’s Administrative Databases

    Nov 1, 2015, 00:00

  • Validation of Periodic Safety Update Reporting System In A Tertiary Care Teaching Hospital Using Adverse Drug Reaction Monitoring of Three Commonly Prescribed Drugs

    Nov 1, 2015, 00:00

  • A Systematic Review of the Humanistic Burden of Gout

    Nov 1, 2015, 00:00

  • Moving Beyond the Picos- Appropriate Comparative Observational Data Selection Can Facilitate Meta-Analysis of Relative Treatment Effects

    Nov 1, 2015, 00:00

  • Cost-Effective Evaluation of Pirfenidone for Treating Idiopathic Pulmonary Fibrosis in Mexico

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Certolizumab Pegol In The Treatment of Axial Spondyloarthritis In Greece

    Nov 1, 2015, 00:00

  • A Novel Tool to Measure The Subjective Burden of Acute Post-Prandial Hyperglycaemia (Pphg)

    Nov 1, 2015, 00:00

  • Optimal Treatment of Chron’s Disease With Biologicals In A Western Balkan Country- Estimates of Cost/Utility By Markov Model And Budget Impact Analysis

    Nov 1, 2015, 00:00

  • Medical Resource Utilisation of Australian Patients With Genotype 1 Chronic Hepatitis C- A Retrospective Observational Study

    Nov 1, 2015, 00:00

  • Prevalence of Transthyretin Familial Amyloid Polyneuropathy In Portugal

    Nov 1, 2015, 00:00

  • Identificação Sistemática de Lacunas de Pesquisa no Âmbito da Saúde Mental Pelo Ministério da Saúde do Brasil

    Nov 1, 2015, 00:00

  • Intensification of Basal Insulin Treatment Among Patients With Diabetes Mellitus Type 2 In The Netherlands

    Nov 1, 2015, 00:00

  • Hospital Cost Analysis Of Patients With Cardiovascular Events And Revascularisation Procedures In Spain

    Nov 1, 2015, 00:00

  • Genotype 1 Hepatitis C Virus Treatments For Non-Cirrhotics In The Era Of All-Oral Direct-Acting Antivirals- A Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Assessment of Unmet Healthcare Needs In Diabetic Patients In Bulgaria

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Sacral Nerve Stimulation for The Treatment of Fecal Incontinence Refractory to Conservative Treatment- Looking for Optimal Treatment Path

    Nov 1, 2015, 00:00

  • A Systematic Review of the Cost Burden of Gout

    Nov 1, 2015, 00:00

  • When Is A Bone Fracture No Longer “Fresh”?

    Nov 1, 2015, 00:00

  • An Undeveloped Picture- The Availability Of Utility Valuations In Latin America – How Will They Affect Qalys?

    Nov 1, 2015, 00:00

  • A Comparison of Three Survival Models to Estimate The Cost-Effectiveness of Cancer Immunotherapy In The Treatment of Advanced Melanoma

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Different Strategies of Monotherapy With Biologic Therapies In Russian Patients With Rheumatoid Arthritis

    Nov 1, 2015, 00:00

  • Value of Antidrug Antibody Screening In Moderate-To-Severe Rheumatiod Arthritis Patients Who Failed Initial Tumor Necrosis Factor-Alpha Treatment

    Nov 1, 2015, 00:00

  • Cost Saving Study Of Five Grass Pollen Slit Tablet Versus Scit’s Symptomatic Treatment

    Nov 1, 2015, 00:00

  • Us Rrms Patient Preferences for Multiple Sclerosis Treatments- An Online Survey

    Nov 1, 2015, 00:00

  • Effect of Antidepressant-Base Treatment of Depressed Patients- an Observation Among Patients with Complete Adherence with Thai Depression Inventory and Lam Employment Absence and Productivity Scale in Psychiatric Hospitals

    Nov 1, 2015, 00:00

  • Value of Assessing the Burden of Hospitalizations for Metastatic Melanoma in the era of Targeted Therapies- Analysis of the French National Hospital Database From 2008 To 2013

    Nov 1, 2015, 00:00

  • Is Oncology Drug Financial Toxicity A Specific Us Issue?

    Nov 1, 2015, 00:00

  • Evidence of Efficacy and Safety of Methylphenidate in the Treatment of Children or Adolescents with Attention Deficit Disorder and Hyperactivity (Adhd)

    Nov 1, 2015, 00:00

  • Where is Your Abdomen? Patient-Reported Abdomen Locations and Implications for Patient-Reported Outcome Assessments

    Nov 1, 2015, 00:00

  • Quantifying The Efficacy-Effectiveness-Gap Using The Example of Metformin

    Nov 1, 2015, 00:00

  • Burden Of Advanced Breast Cancer For Patients And Caregiver In Europe- Comparisons Of Two Treatment Forms Of Vinorelbine, Oral And Intravenous

    Nov 1, 2015, 00:00

  • Predicting Future Need Of Resources For Adenoma Surveillance From A Population-Based Colorectal Cancer Screening Program Through Discrete Event Simulation

    Nov 1, 2015, 00:00

  • Projected Economic Impact of Increased Use of Biologic Treatments For Rheumatoid Arthritis In Argentina, Colombia, And Mexico Over 10 Years

    Nov 1, 2015, 00:00

  • Pharmaceutical Products And Vaccines Discussed In Social Media- Which Ones Are Patients Talking About?

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland

    Nov 1, 2015, 00:00

  • Can Grapefruit Juice Make Safe Drugs Unsafe or Ineffective? An Evidence-Based Answer

    Nov 1, 2015, 00:00

  • A Systematic Literature Review And Network Meta-Analysis of Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for The Treatment of Painful Diabetic Peripheral Neuropathy

    Nov 1, 2015, 00:00

  • Gastos En Salud En La Intervencion De Tratamiento Y Control De Pacientes Con Hipertension Arterial Del Programa Presupuestal De Enfermedades No Transmisibles En El Perú-2012-2014

    Nov 1, 2015, 00:00

  • Systematic Review and Meta-Analysis of Self-Monitoring and Self-Management of Anticoagulation Therapy with Vitamin K Antagonists

    Nov 1, 2015, 00:00

  • Medical Devices For Ostomates. Cost And Quantity Characteristics In Slovakia 2009 - 2013

    Nov 1, 2015, 00:00

  • The Pediatric Asthma Patient Registry In Implementation Of Long Term Follow Up

    Nov 1, 2015, 00:00

  • Estudio De Impacto Presupuestal De Daclatasvir Asociado A Asunaprevir Desde La Perspectiva Del Sistema De Salud Publico Chileno

    Nov 1, 2015, 00:00

  • A Cross-Sectional Assessment of Health-Related Quality of Life Among Type 2 Diabetic Patients In Pakistan

    Nov 1, 2015, 00:00

  • Occupational Disability and Economic Deprivation of Individuals Suffering from Treated Mental Health Disorders

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Tocilizumab Versus Adalimumab As A First Line (1l) Monotherapy For The Treatment of Patients With Rheumatoid Arthritis (Ra) In Greece

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Herpes Zoster Vaccination In Hong Kong

    Nov 1, 2015, 00:00

  • The Economic Burden of Mental Disorders in Korea

    Nov 1, 2015, 00:00

  • The Remote Monitoring Technologies In The Patient Risk Management

    Nov 1, 2015, 00:00

  • Socioeconomic Burden of Autism In Children In Greece

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Sodium Oxybate In Treatment of Cataplexy In Patients With Narcolepy In Turkey

    Nov 1, 2015, 00:00

  • Modeling of Using Rilpivirine/ Tenofovir/ Emtricitabine In Treatment of Naïve Hiv-1 Infected Patiens

    Nov 1, 2015, 00:00

  • Cross-Sectional Descriptive Study Of The Impact Of Anaemia In Patients With Chronic Kidney Disease On Healthcare Resource Utilisation And Work Productivity Across Europe

    Nov 1, 2015, 00:00

  • The Relationship Between Disease Severity and Quality of Life In Patients With Moderate to Severe Psoriasis

    Nov 1, 2015, 00:00

  • Personalised Breast Screening- Key Drivers Of Cost Effectiveness

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Intravitreal Aflibercept In The Treatment of Neovascular Age-Related Macular Degeneration In Greece

    Nov 1, 2015, 00:00

  • Health Related Quality Of Life Of Caregivers And Patients Treated For Metastatic Non-Small Cell Lung Cancer (Nsclc) With Oral Vinorelbine

    Nov 1, 2015, 00:00

  • Estudio De Costo Efectividad Entre el Implante de Ahmed Versus el Implante de Baerveldt en Pacientes Operados De Glaucoma Crónico

    Nov 1, 2015, 00:00

  • SERIOUS POST-OPERATIVE INFECTIONS INCREASE RESOURCE UTILIZATION, LENGTH OF STAY, AND INPATIENT MORTALITY IN PEDIATRIC PATIENTS UNDERGOING BRAIN TUMOR RESECTION

    Nov 1, 2015, 00:00

  • The Economic Consequences of the use of Antidepressants in Belgium

    Nov 1, 2015, 00:00

  • Distribución Geográfica y Acceso a Terapias Biológicas en Pacientes Con Diagnóstico de Artritis Reumatoide (Ar) en Colombia

    Nov 1, 2015, 00:00

  • To Access Independent Risk Cause Of Sudden Cardiac Death In Hemodialysis Patients

    Nov 1, 2015, 00:00

  • Simeprevir Plus Peginterferon/Ribavirin Cost-Effectiveness Analysis for the treatment of Chronic Genotype 1 Hepatitis C in Colombia

    Nov 1, 2015, 00:00

  • A Cost-Effective Analysis of Revolution Ct for Patients With Acute Chest Pain

    Nov 1, 2015, 00:00

  • Climate Measurement of Patient Safety in the Health Service-Portuguese Version of the Safety Attitudes Questionnaire Short Form 2006

    Nov 1, 2015, 00:00

  • Table of Contents

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Ginkgo Biloba Extract (Egb761® - Tanakan®) for The Treatment of Dementia In The Czech Republic

    Nov 1, 2015, 00:00

  • Cost Consequence Of Preventive Treatment With Om 85 Bacterial Lysate Compared To The Same Patients Without Om 85 The Previous Year In Allergic Rhinitis, Asthma And Copd In Argentina

    Nov 1, 2015, 00:00

  • Healthcare Resource Consumption And Costs Before And After Kidney Transplantation In Lombardy, Italy

    Nov 1, 2015, 00:00

  • Is There A Relationship Between Patient-Reported Outcomes (Pros) And Clinical Outcomes In Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Post-Docetaxel?

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Granulocyte Colony-Stimulating Factors For The Prophylaxis Of Chemotherapy-Induced Febrile Neutropenia In Patients With Non-Hodgkin’s Lymphoma In Greece

    Nov 1, 2015, 00:00

  • Total Cholesterol (Tc), Low-Density Lipoprotein Cholesterol (Ldl-C) And High-Density Lipoprotein Cholesterol (Hdl-C) Levels In Patients With Hypertension (Ht), Diabetes (Dm), Both (Ht And Dm) And Chronic Kidney Disease (Ckd)

    Nov 1, 2015, 00:00

  • Development of a Measure to Assess Severity of Mps Ii- the Disease Severity Score

    Nov 1, 2015, 00:00

  • Lets Talk! Is Chatter on Social Media Amongst Participants Compromising Clinical Trials?

    Nov 1, 2015, 00:00

  • Analisis de Impacto Presupuestal del uso de Daclatasvir+Asunaprevir en el Tratamiento de Pacientes Con Hepatitis C en Colombia

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Testing for Brca1 and Brca2 Mutations In Women Diagnosed With Ovarian Cancer and Their Female First- And Second Degree Relatives Using A Discrete Event Simulation- A Uk Health Service Perspective

    Nov 1, 2015, 00:00

  • Health-Related Quality Of Life And Treatment Satisfaction Among Patients Receiving Novel Anti-Androgen Therapies For The Treatment Of Metastatic Castrate-Resistant Prostate Cancer (Mcrpc)

    Nov 1, 2015, 00:00

  • Differences In Pharmacists’ Skin Cancer Prevention Strategies by Age and Gender

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ponatinib Followed By Stem Cell Transplant Versus Best Supportive Care For Uk Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia After Failure of Dasatinib

    Nov 1, 2015, 00:00

  • Epidemiological Burden and Management of Hypercholesterolemia in High Cardiovascular Risk Patients in Spain- a Comprehensive Picture from a Systematic Review of the Literature

    Nov 1, 2015, 00:00

  • Cost Effectiveness Analysis of Eribulin Mesylate (Halaven®) as a Treatment for Metastatic Breast Cancer in Mexico

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis for The Use of The Ccp Score In The Management of Early Low Risk Prostate Cancer In The French Context

    Nov 1, 2015, 00:00

  • Prevalence And Burden Cost Of Adverse Drug Reactions (Adrs) In The Faculty Of Medicine Vajira Hospital Navaminthradhiraj University - A Research Implemented To Policy Recommendations

    Nov 1, 2015, 00:00

  • Comprehensive Review of Orphan Drugs Post-Amnog In Germany

    Nov 1, 2015, 00:00

  • Consensus of Clinical Practices And Associated Costs To Diagnose And Treat Genital Warts Caused By Human Papilloma Virus (Hpv) In Ecuador- Results From A Panel Of Experts

    Nov 1, 2015, 00:00

  • Economic Justification Of Telemedicine Technology For Preventive Medical Examination Of The Population In Remote Regions In Russia

    Nov 1, 2015, 00:00

  • Cost Impact of The Delay of Broad-Spectrum Antimicrobial Agents De-Esclation on Surgical Wards

    Nov 1, 2015, 00:00

  • Prospective Study Of Radiation Related Adverse Events And Its Management In Cancer Patients— A Pilot Study

    Nov 1, 2015, 00:00

  • A Loss of Chance Index- a New Tool for Optimizing Patient Access to Innovative Drugs

    Nov 1, 2015, 00:00

  • Systematic Review Of Burden Of Pancreatic Cancer

    Nov 1, 2015, 00:00

  • Human Health Damage Modelling in Life Cycle Assessment- A Valuable Addition to the Evaluation of Medical Interventions?

    Nov 1, 2015, 00:00

  • Prevalence Of Depression And Anxiety And Their Risk Factors In Women With Breast Cancer In German Primary Care

    Nov 1, 2015, 00:00

  • Updated Medication Costs From A Real-Life Cost-Effectiveness Evaluation Of Budesonide/Formoterol Maintenance And Reliever Therapy In Asthma Maintenance And Reliever Therapy In Asthma

    Nov 1, 2015, 00:00

  • Assessing Equity Of Health Service Utilization Of Rural Residents In China- A Case Study Of Z County, Shaanxi Province

    Nov 1, 2015, 00:00

  • Health Technology Assessment Tools for Technologies Incorporation into Public Health System

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Palivizumab In Children With Congenital Heart Disease In Mexico

    Nov 1, 2015, 00:00

  • Economic Analysis Of Evarrest® Sealant Matrix Compared With Standard Of Care In Severe Soft Tissue Surgical Bleeding- A United Kingdom Hospital Perspective

    Nov 1, 2015, 00:00

  • Measuring Preference-Based Patient Benefit of Medical Devices- a New Instrument for Health Economic Assessments

    Nov 1, 2015, 00:00

  • Analysis of Clinical and Economic Implications of Esmo 2014 Clinical Practice Guidelines for Metastatic Colorectal Cancer Treatment

    Nov 1, 2015, 00:00

  • The Budget Impact Of An Inhaler With Improved Features Compared To Spiriva® Handihaler® For The Management Of Chronic Obstructive Pulmonary Disease (Copd) In The Uk- Estimated Impact On Unscheduled Healthcare Costs And Inhaler Satisfaction

    Nov 1, 2015, 00:00

  • Patient Characteristics And Treatment Patterns In Er+/Her2- Metastatic Breast Cancer In The Uk- Results From A Retrospective Medical Record Review

    Nov 1, 2015, 00:00

  • Dose Escalation Among Ulcerative Colitis Patients Treated With Adalimumab In Sweden

    Nov 1, 2015, 00:00

  • Aflibercept in Combination with Folfiri in Patients with Metastatic Colorectal Cancer- Cost-Effectiveness Based on Velour Best Efficacy Subgroup Post-Hoc Analysis

    Nov 1, 2015, 00:00

  • Cost Consequences Of Single-Use And Re-Use Of Urinary Catheters Among Patients Performing Daily Intermittent Catheterization

    Nov 1, 2015, 00:00

  • Avaliação Da Eficácia E Segurança Do Ibuprofeno Versus Demais Anti-Inflamat”Rios Não Esteroidais, No Tratamento De Recém-Nascidos Prematuros Com Persistência Do Canal Arterial

    Nov 1, 2015, 00:00

  • The Impact of Healthcare Policy Based on Drug Plan Perspective Versus The Ministry of Health Perspective- A Case Study of The Odprn Recommendations of Restricting Reimbursement of Testosterone Replacement Therapy For Hypogonadism In Ontario ...

    Nov 1, 2015, 00:00

  • Use Of Budget Impact Analysis (Bia) In Economic Evaluations Of Drugs And Medical Devices Submitted To The French National Authority For Health (Has)

    Nov 1, 2015, 00:00

  • The Structure of The Choroid Plexus of Adult and Children Brain Ventricles

    Nov 1, 2015, 00:00

  • Bemfola® Can Potentially Reduce Drug Wastage and Associated Costs of Intertility Treatment

    Nov 1, 2015, 00:00

  • Caracterización De La Población Con Diagnóstico De Hemofilia De Un Programa De Seguimiento A Pacientes De Un Grupo De Empresas Administradoras De Planes De Beneficio Colombianas

    Nov 1, 2015, 00:00

  • Direct Costs And Length of Stay In Patients With Methicillin Resistant Versus Methicillin Sensitive Staphylococcus Aureus Infection In A Tertiary Care Hospital In India

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Using Golimumab In The Care of Patients With Ulcerative Colitis

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Conjugated Estrogens/Bazedoxifene for the Treatment of Vasomotor Symptoms in the United States

    Nov 1, 2015, 00:00

  • Drug use Among Elderly in the year Before Colon Cancer Diagnosis Versus Matched Cancer-Free Controls

    Nov 1, 2015, 00:00

  • Patient Understanding and Attitudes About Biosimilars- An International Cross-Sectional Survey

    Nov 1, 2015, 00:00

  • Ranibizumab Vs. Verteporfin Photodynamic Therapy for The Treatment Of Myopic Choroidal Neovascularization- Cost Effectiveness Study In Portugal

    Nov 1, 2015, 00:00

  • Stakeholder Views On The Acceptability Of Real-World Evidence For Informing Trial Design And Assessment Of Relative Effectiveness Of New Medicines

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Carfilzomib for the Treatment of Relapsed Refractory Multiple Myeloma (Mm) in Mexico

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of A Left Atrial Appendage Closure Device In Patients With Non-Valvular Atrial Fibrillation Unable or Unwilling to Tolerate Oral Anticoagulant Therapy In Italy And Spain

    Nov 1, 2015, 00:00

  • Differentials In Contraceptive Use Among Currently Married Women By Socio-Demographic Characteristics In Western Kenya

    Nov 1, 2015, 00:00

  • “Big Data” In Alzheimer’s Disease Research- An Environmental Scan

    Nov 1, 2015, 00:00

  • Systematic Review of Economic Evaluations In Multidisciplinary Pain Management Services for Managing People With Fibromyalgia or Chronic Widespread Pain

    Nov 1, 2015, 00:00

  • Costo de Enfermedades Metaxenicas en Los Establecimientos de Salud del Perú

    Nov 1, 2015, 00:00

  • A Budget Impact Analysis To Estimate The Economic Consequences Of An Increase Of Medication Compliance Related To A Potential Improvement Of The Inhalation Technique With Spiromax® Compared With Turbuhaler® In Moderate To Severe Asthmatic P ...

    Nov 1, 2015, 00:00

  • Real-World Assessment of Relapse, Medical Costs and Persistency of Multiple Sclerosis Patients Treated With Subcutaneous Interferon β-1a

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Gestational Diabetes Mellitus Screening in Urban Chinese Setting

    Nov 1, 2015, 00:00

  • Brexit and Grexit- Implications for The Pharmaceutical Industry

    Nov 1, 2015, 00:00

  • Price Fluctuations Across Lifecycle- Insights From The Anti-Vegf Market

    Nov 1, 2015, 00:00

  • Equivalence of Paper and Electronic Administration of Patient Reported Outcomes- a Comparison in Psoriatic Arthritis

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analyses In France, England And Canada- Comparative Analysis Of Structural Choices, Results And Perspectives

    Nov 1, 2015, 00:00

  • Validation of The Spanish Version of The Urticaria Activity Score (Uas) and Its Use Over One Week (Uas7)

    Nov 1, 2015, 00:00

  • Health State Utilities of Risks Associated with Antiretroviral Treatment for Human Immunodeficiency Virus (Hiv)

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of Treatment Of Patients With Acute Coronary Syndrome Without St Segment Elevation In Ukraine

    Nov 1, 2015, 00:00

  • Market Access for Pharmaceuticals In Europe- Future Perspectives

    Nov 1, 2015, 00:00

  • Patient use of Eclinical Technology to Research, Track, And Self-Manage Chronic Disease

    Nov 1, 2015, 00:00

  • Patients’ Preferences for Rheumatoid Arthritis Treatments and their Participation in the Treatment Decision-Making Process. A Systematic Review of the Literature

    Nov 1, 2015, 00:00

  • Internal Structure of the Minnesota Living with Heart Failure Questionnaire

    Nov 1, 2015, 00:00

  • Comparison of Social Eq-5d Time Trade-Off Values In Chile 2008-2013- Do Geographical Differences Really Matter?

    Nov 1, 2015, 00:00

  • Comparison of Two Methods for Estimation of Work Limitation Scores from Health Status Measures

    Nov 1, 2015, 00:00

  • Quantifying The Short-Term Impact of Changes In Hba1c, Weight And Insulin Regimen on Health Related Quality-of-Life

    Nov 1, 2015, 00:00

  • Medical Devices – From Licensing To Coverage- Highlights From Argentina, Brazil, Colombia, And Mexico

    Nov 1, 2015, 00:00

  • The Maps Reporting Statement for Studies Mapping onto Generic Preference-Based outcome Measures

    Nov 1, 2015, 00:00

  • Assessing The Burden of Systemic Lupus Erythematosus In Belgium Using A Longitudinal Hospital Database

    Nov 1, 2015, 00:00

  • Direct Medical Costs Associated With Ankylosing Spondylitis In Chinese Patients- Estimations From China Public Health Insurance Claim Data

    Nov 1, 2015, 00:00

  • Incidence and Prevalence Estimations Based on Claims Data – New Methodological Considerations

    Nov 1, 2015, 00:00

  • Assessment of a Predictive Risk Model for Classifying Patients with Multimorbidity in the Basque Country

    Nov 1, 2015, 00:00

  • The Economic Burden of Pharmaceuticals in People Diagnosed with Depression, Anxiety-Related Disorder and Substance use in Australia

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Dasatynib In Treatment of Adult Patients With Philadelphia Chromosome Positive (Ph+) Acute Lymbphoblastic Leukemia (All) With Resistance or Intolerance to Prior Therapy In Poland

    Nov 1, 2015, 00:00

  • Title- Factors Influencing Consumers’ Perceived Risk Of Tobacco Products

    Nov 1, 2015, 00:00

  • A Triple Aim Framework For The Performance Assessment Of Disease Management Programs

    Nov 1, 2015, 00:00

  • Epidemiologic and Economic Burden Attributable to First Spinal Fusion Surgery- Analysis From An Administrative Database

    Nov 1, 2015, 00:00

  • Statistical Assessment of a Case-Finding Algorithm for Identifying Non-Small Cell Lung Cancer (Nsclc) Patients in Administrative Claims Databases

    Nov 1, 2015, 00:00

  • Effect of Parallel Review Processes for the Marketing Authorization and Reimbursement to Patients and Budget

    Nov 1, 2015, 00:00

  • Evaluacion Economica Del Seguimiento Farmacoterapéutico En Pacientes Con Trastorno Afectivo Bipolar I

    Nov 1, 2015, 00:00

  • Estimating the Budget Impact of Switching from Bortezomib Intravenous (Iv) to Bortezomib Subcutaneous (Sq) in the Treatment of Relapsed/Refractory Multiple Myeloma (Mm) in Mexico

    Nov 1, 2015, 00:00

  • The Potential For Improved Inhalation Technique With Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Commonly Prescribed Dry Powder Inhalers For The Management Of Asthma And Chronic Obstructive Pulmonary Diseas ...

    Nov 1, 2015, 00:00

  • Evaluation of The Cost Effectiveness of Rifaximin-Á In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Belgium

    Nov 1, 2015, 00:00

  • Evaluation of Cost of Managing Hepatitis C In Greece Across All Disease Stages and The Potential Value of Simeprevir Triple Regimen As A Treatment Option In The Early Stages

    Nov 1, 2015, 00:00

  • Cross-Country Profile of Adult Caregivers

    Nov 1, 2015, 00:00

  • Indicadores De Nefroportección- Herramienta Para Evaluar Resultados En Gestión De Riesgo Para Pacientes Con Enfermedad Renal Cronica, Hipertensión Y/O Diabetes Mellitus En Colombia

    Nov 1, 2015, 00:00

  • A Practical Guide To Adding Patient Heterogeneity Into Phase Iii Trials- Results from Imi Getreal Wp2

    Nov 1, 2015, 00:00

  • Quality of Life of Hiv-Infected Patients Attending to A University Infectious Diseases Clinic In Venezuela

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Apixaban Compared to Low Molecular Weight Heparin/ Edoxaban for Treatment and Prevention of Recurrent Venous Thromboembolism

    Nov 1, 2015, 00:00

  • Modeling Of Clinical Pathways In The Implantation Of Cardioverter Defibrillators From 2006 To 2013 Using The French Hospital P.M.S.I. Database

    Nov 1, 2015, 00:00

  • Cost-Minimization Analysis of Intravitreal Aflibercept Compared with Ranibizumab on-Label In Patients with wet Age-Related Macular Degeneration (Wamd)

    Nov 1, 2015, 00:00

  • Costo-Efectividad De Un Programa De Nefroproteccion En Una Cohorte De 17.000 Pacientes Con Enfermedad Renal Cronica Afiliados A Una Aseguradora En Salud En Colombia

    Nov 1, 2015, 00:00

  • Diabetes In Turkey- Analysis of Patient Characteristics

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Vemurafenib as a First-Line Treatment in Patients with Braf V600 Mutation-Positive Unresectable or Metastatic Melanoma in Spain

    Nov 1, 2015, 00:00

  • Potential Societal Value of Biosimilars Adoption- The Example of UK

    Nov 1, 2015, 00:00

  • How French Subjects Describe Well-Being from food and Eating Habits? Development, and Scoring Definition of the well-Being Related to food Questionnaire (Well-Bfq©)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Cardioprotective Effect of Dexrazoxane (Cardioxane®) in Advanced/Metastatic Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy in México

    Nov 1, 2015, 00:00

  • Dispensing Frequency among Patients with Rheumatoid Arthritis Treated with Rituximab in England

    Nov 1, 2015, 00:00

  • Economic Costs of Bacterial Meningitis- A Systematic Review

    Nov 1, 2015, 00:00

  • Organizational Models of Hospital Based HTA- Empirical Evidence from Adhophta European Project

    Nov 1, 2015, 00:00

  • Assessment of Tofacitinib For Rheumatoid Arthritis From The Perspective of The Brazilian Healthcare System

    Nov 1, 2015, 00:00

  • Impact of Financial Incentives on Access to Services and Quality of Care

    Nov 1, 2015, 00:00

  • Introduction Of Mirabegron In The Czech Republic From Payer’s Perspective – 1 Year Overview

    Nov 1, 2015, 00:00

  • Health Care Resource Utilization and Direct Medical Costs Among Patients With Epilepsy In Tianjin, China

    Nov 1, 2015, 00:00

  • Patient Characteristics and Disease Burden of Osteoporosis In Post Menopausal Women At Increased Risk of Fracture In Germany

    Nov 1, 2015, 00:00

  • Regulatory Approval for Oncology Products In Brazil- A Comparison Between The Fda And Anvisa Approval Timelines

    Nov 1, 2015, 00:00

  • Prices Changes for Patent-Protected Innovative Drugs in the Top 5 Eu Pharmaceutical Markets

    Nov 1, 2015, 00:00

  • Identification of Osteoporosis Chronic Inflammatory Rheumatic Disease In French Claims Data

    Nov 1, 2015, 00:00

  • Cost-Minimization Analysis (CMA) of Canagliflozin Compared to Glimepiride and Sitagliptin as Dual Therapy in Combination with Metformin

    Nov 1, 2015, 00:00

  • Tracking Drug Utilization Data to Enable Conditional Reimbursement of Medicines or Specific Indications In Romania- Analysis of The Requirement for An Effective Implementation

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of The Use of Voriconazole, Posaconazole And Micafungin In The Primary Prophylaxis of Invasive Fungal Infections In Recipients of Allogeneic Hematopoietic Stem Cell Transplants In Spain

    Nov 1, 2015, 00:00

  • The Conceptual Framework of Quality of Sexual Life in Hiv and Hcv

    Nov 1, 2015, 00:00

  • Análisis de Costo-Efectividad de Anidulafungina en el Tratamiento de la Candidiasis Invasiva en Colombia

    Nov 1, 2015, 00:00

  • Risk of New-Onset Diabetes Associated with Concomitant Antidepressant, Inhaled Corticosteroids, and Statin Use Among Medicaid Beneficiaries with COPD

    Nov 1, 2015, 00:00

  • Survey of Neurologist’s Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure

    Nov 1, 2015, 00:00

  • Brazilian Guideline for Academic Detailing- a Need to Improve Health Care

    Nov 1, 2015, 00:00

  • The Association Between Smoking Cessation Outpatient Visits And Total Medical Costs- An Analysis Of Japanese Employee Based Public Health Insurance Data

    Nov 1, 2015, 00:00

  • Inconsistency in the Valuations of Euroqol Eq-5d-5l Health States in China was More Related to Interviewer and to Interview Process than to Respondents’ Characteristics

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Drugs- Systematic Review

    Nov 1, 2015, 00:00

  • Knowledge On The Appropriate Technique Of Bloos Pressure Monitoring And Limits Of The Oscillometric Blood Pressure Measurement

    Nov 1, 2015, 00:00

  • Assessment Of Pharmacist-Led Home-Based Educational Intervention Among Type 2 Diabetes Patients In The State of Penang, Malaysia

    Nov 1, 2015, 00:00

  • Consumo De Benzodiazepinas En La Poblacion Geriatrica Atendida En El Hospital Clinico Regional De Concepcion

    Nov 1, 2015, 00:00

  • Association Among Calendar Packaging And Medication Adherence- Findings From A Focus Group Discussion Among Hypertensive Patients In Penang, Malaysia

    Nov 1, 2015, 00:00

  • Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index- Convergences and Divergences

    Nov 1, 2015, 00:00

  • Disease Burden, Outcomes and Costs Among Adults Admitted To Hospital In The United Kingdom (Uk) Due to Plaque Or Erythrodermic Psoriasis

    Nov 1, 2015, 00:00

  • Early Health Economic Assessment in Innovation Partnerships- Lessons from the European Innovation Partnership on Active and Healthy Ageing

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Apremilast on Moderate to Severe Psoriasis In Spain

    Nov 1, 2015, 00:00

  • Economic Study Design for the Optimize Study on Orbital Atherectomy and Drug-Coated Balloon Devices for the Treatment of Below-The-Knee Peripheral Arterial Disease

    Nov 1, 2015, 00:00

  • Characteristics of Acne Vulgaris In European Adolescents And Patients Perceptions

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ruxolitinib for The Treatment of Myelofibrosis In Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

    Nov 1, 2015, 00:00

  • Impact of Grexit on Pharmaceutical Pricing- An International Reference Pricing Analysis

    Nov 1, 2015, 00:00

  • Sugar Free Gum- Impact on Oral Health and Copayment In Germany

    Nov 1, 2015, 00:00

  • Validation of a Short “Occupational Disability Index” As a Measure for Disease Impacts on Work Performance and Occupational Handicaps

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Manual Therapy Versus Physical Therapy In Patients With Sub-Acute and Chronic Neck Pain- A Randomized Controlled Trial

    Nov 1, 2015, 00:00

  • Analysis of the Reports of the National Committee for Technology Incorporation (Conitec) in the Brazilian Public Health System (Sus), 2012-2015

    Nov 1, 2015, 00:00

  • External Reference Pricing from the Perspective of Slovenia

    Nov 1, 2015, 00:00

  • A Cross-Sectional Epidemiological Cancer Registry In Egypt

    Nov 1, 2015, 00:00

  • Doctors’ Failure In Observance Of The Copd Management Guidelines- The Czech Republic 2015 Update

    Nov 1, 2015, 00:00

  • Relapsing Remitting Multiple Sclerosis Patients Initiated on Oral Dmf Report A Better Quality of Life Compared to Patients on Platform Therapies As Measured By Eq-5d

    Nov 1, 2015, 00:00

  • Trial Design and Market Access Implications- Outcomes from Comparator Choice

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% for Actinic Keratosis Treatment In Spain

    Nov 1, 2015, 00:00

  • Appraising The Cost Of Physician Visits And Technical Procedures In France In The Age Of Open Data

    Nov 1, 2015, 00:00

  • Delays in Diagnosis of Breast Cancer in Gree Findings from a Qualitative Study

    Nov 1, 2015, 00:00

  • Data Framework To Improve Relationship In Drugs Therapies Between Gps And Hospital Physicians

    Nov 1, 2015, 00:00

  • Costo En Salud De La Intervenci”N En La Atenci”N Del Parto Normal En El Peru 2009 Y 2014

    Nov 1, 2015, 00:00

  • Predictive Analysis of Factors Influencing Health Technology Assessment Recommendation- A Literature Review

    Nov 1, 2015, 00:00

  • Evaluación Económica del uso de La Gasa Sintética Frente a la Gasa de Algodón de Pieza Única En El Manejo de Heridas en Colombia

    Nov 1, 2015, 00:00

  • Do Not Overlook Your Country-Specific Characteristics- The Case Of Baroreflex Activation Therapy (Bat) For The Treatment Of Resistant Hypertension

    Nov 1, 2015, 00:00

  • Wintertime Surgery Increases The Risk of Osteonecrosis After Internal Fixation of Femoral Neck Fracture

    Nov 1, 2015, 00:00

  • Health Economic Evaluation of Different Vaccination Strategies Against Varicella and Herpes Zoster in Germany

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of The Fixed Combination Indacaterol/Glycopyrronium Vs. Tiotropium And Salmeterol/ Fluticasone In The Management Of Copd In Greece

    Nov 1, 2015, 00:00

  • Using Machine Learning To Populate A Markov Model By Mining Big Data Directly From Hospital Ehrs – An Application To Dynamically Predict Hospital-Acquired Pressure Ulcers

    Nov 1, 2015, 00:00

  • Tailoring Sponsor-Payer Engagement to Facilitate Effective and Fair Patient Access

    Nov 1, 2015, 00:00

  • The Impact of Consumer-Directed Health Plans on Price Shopping

    Nov 1, 2015, 00:00

  • Competition And Strategic Regulation In The Argentine Pharmaceutical Market- A Comparative Study Of Six Therapeutic Classes

    Nov 1, 2015, 00:00

  • A Systematic Literature Review of Economic Burden of Myelofibrosis

    Nov 1, 2015, 00:00

  • Priority issues and Recommendation Selection in Cancer Pain Management

    Nov 1, 2015, 00:00

  • The Evolution of HTA as a Coverage Decision-Making Tool in the Middle East and North Africa Region

    Nov 1, 2015, 00:00

  • Stochastic Multicriteria Acceptability Analysis In A Bayesian Framework

    Nov 1, 2015, 00:00

  • Excess Costs Associated With Possible Misdiagnosis of Alzheimer’s Disease Among Patients With Vascular Dementia In Italy

    Nov 1, 2015, 00:00

  • A Systematic Review of The Impact of Improved Housing Interventions on Health In Low And Middle Income Tropical Settings

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Quadrivalent Human Papilloma Virus (Hpv6/11/16/18) Vaccination In Ecuador

    Nov 1, 2015, 00:00

  • Understanding The Underutilisation Of Evidence From Economic Evaluations In Healthcare- A Mixed Methods Design

    Nov 1, 2015, 00:00

  • Costo-Efectividad De Los Nuevos Anticoagulantes Orales En Pacientes Con Fibrilacion Auricular No Valvular En Colombia

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Sitagliptin Compared to Sulphonylurea as an Add-on to Metformin in the Treatment of Type 2 Diabetes in Greece

    Nov 1, 2015, 00:00

  • Humanistic and Economic Burden of Focal Drug-Refractory Epilepsy In Europe

    Nov 1, 2015, 00:00

  • Eastern Cooperative Oncology Group (Ecog) Performance Status (Ps) Is An Independent Predictor Of Hrqol In Unresectable Or Metastatic Melanoma

    Nov 1, 2015, 00:00

  • Anchoring Bias in Tto Valuations

    Nov 1, 2015, 00:00

  • Estimaci”N de Costos Directos Asociados al Cambio de Terapia iv A oral en Infecci”N Complicada de Piel y Tejidos Blandos en Chile

    Nov 1, 2015, 00:00

  • Hexaminolevulinate Blue-Light Flexible Cystoscopy In Addition To Standard White-Light Cystoscopy In The Follow-Up Of Non-Muscle Invasive Bladder Cancer- Cost-Consequences During Outpatient Surveillance In Sweden

    Nov 1, 2015, 00:00

  • Measuring Generic Health-Related Quality Of Life And Impact Of Health Resource Utilization In Adults With Cystic Fibrosis

    Nov 1, 2015, 00:00

  • Economics of Diabetes Mellitus- Theory And Evidence For Brazilian Data In 2008

    Nov 1, 2015, 00:00

  • Investigating The Accessibility Of Uninsured Population To Health Services In Greece

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Secukinumab Compared to Ustekinumab In The Treatment of Moderate to Severe Plaque Psoriasis In The Czech Republic

    Nov 1, 2015, 00:00

  • Governance, Decision-Making, and Universal Health Coverage- perceptions from Chilean Health Decision-Makers

    Nov 1, 2015, 00:00

  • Importance of Hypoglycemia Barrier on The Treatment of Diabetes Mellitus (Dm) – Survey With Turkish Physicians

    Nov 1, 2015, 00:00

  • Medical Cost Of Patients With Non-Valvular Atrial Fibrillation (Nvaf) And Treated With Vitamin K Antagonists (Vkas) According To Inr Control Status In Spain

    Nov 1, 2015, 00:00

  • Quantifying the Impact of Health-Related Quality of life (Hrql) on Medical Expenditures in Asthma, arthritis, Depression, Diabetes, and Migraine

    Nov 1, 2015, 00:00

  • Use Pattern Narcotic Analgesics For Cancer Patient In South Korea - Claims Data Analysis

    Nov 1, 2015, 00:00

  • Rivaroxavan+Enoxiparina Comparado A Enoxiparina En Pacientes Postoperador De Remplazo Articular De Rodilla Y Cadera

    Nov 1, 2015, 00:00

  • Evaluation Of Resource Utilizaton For Chemotherapy Induced Nausea And Vomiting (Cinv) In Patients Treated With Anthracycline+Cyclophosphamide (Ac) For Solid Cancers With And Without Nk-1 Based Regimens

    Nov 1, 2015, 00:00

  • Estimating The Burden Of Diabetes To The French National Health Insurance

    Nov 1, 2015, 00:00

  • Measurement Invariance of the Whoqol-Old Module Across Different Demographic Groups in Taiwan’s Elderly People

    Nov 1, 2015, 00:00

  • Mapping the Diagnostic Pathway for Breast Cancer in England and Comparison to Europe

    Nov 1, 2015, 00:00

  • Endovascular Interventions For Treatment Of Femoropopliteal Peripheral Artery Disease- Updated Budget Impact Analysis For Germany Based On Latest Clincal Evidence

    Nov 1, 2015, 00:00

  • Does A Shorter Protocol Time for Chest Pain Patients Impact Emergency Department Flow? A Queuing Model to Discuss Emergency Department Management Metrics

    Nov 1, 2015, 00:00

  • An Economic Analysis of Informal Care Provision in Ireland

    Nov 1, 2015, 00:00

  • Comparing Cost-Effectiveness Of Emerging Drugs In Advanced Cancer Without Hazard Ratios For Progression

    Nov 1, 2015, 00:00

  • Increased Risk of Osteoporosis In Depressed Patients- A Real World Data Study Conducted In Italy

    Nov 1, 2015, 00:00

  • Anthropometric Study on Mongolians with Metabolic Syndrome

    Nov 1, 2015, 00:00

  • Pro Claims in Fibromyalgia- A Review of the Labels of Products Approved by the Fda and the Ema

    Nov 1, 2015, 00:00

  • Extended-Release Oxycodone Hydrochloride (Oxycontin®) for Pain Management In Patients Undergoing Arthroplasty- A Cost Analysis From The Brazilian Public and Private Healthcare Systems Perspectives

    Nov 1, 2015, 00:00

  • Health Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine In Finnish Home Care Customers ≥50 Years With Underlying Chronic Medical Conditions

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Pramipexole Extended Release Monotherapy In Early Parkinson`S Disease

    Nov 1, 2015, 00:00

  • How ready are european payers for ema adaptive pathways?

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ikervis® In Severe Dry Eye Disease In The Uk [Update]

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Canacinumab In The Treatment of Patients With Muckle–Wells Syndrome In The Russian Federation

    Nov 1, 2015, 00:00

  • Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study

    Nov 1, 2015, 00:00

  • A Cross-Sectional Analysis of Recently Published Systematic Literature Reviews on Pharmacological Interventions in Oncology

    Nov 1, 2015, 00:00

  • Persistence and Econ”Mic Impact of Etanercept and Adalimumab Dose Reduction In Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Patients With At Least 1 Year In Clinical Remission- Experience From 2 Spanish Teaching Ho ...

    Nov 1, 2015, 00:00

  • Adjusting For Cross-Over In Oncology Trials- Approaches Taken To Support Drug Reimbursement In Australia

    Nov 1, 2015, 00:00

  • Assessing The Rationality of Costs of Drug Treatment of Nonalcoholic Steatohepatitis In The Hospital of Ukraine

    Nov 1, 2015, 00:00

  • Comparison Of T-Piece Resuscitator With Other Flow – Inflating Bags For Providing Positive Pressure Ventilation During Neonatal Resuscitation- A Systematic Review

    Nov 1, 2015, 00:00

  • Telephone Versus face-to-face Interviews for Patient-Reported Outcome Instrument Development

    Nov 1, 2015, 00:00

  • A Validity and Reliability Study of the Poverty Related Quality of Life Questionnaire in a Turkish Patient Population

    Nov 1, 2015, 00:00

  • Scoring and Measurement Properties of a Tool to Assess Primary Care Physicians’ Engagement in and Perceived Barriers to Vaccination- the ‘Determinant of Intentions of Vaccination’ (Diva©) Questionnaire

    Nov 1, 2015, 00:00

  • Utilizacion De Servicios De Salud Para El Tratamiento De Cáncer De Pulmon En Venezuela

    Nov 1, 2015, 00:00

  • Propuesta De Un Indicador Que Valore La Carga De Enfermedad Desde La Perspectiva Del Riesgo Y Costos En Una Entidad Promotora De Salud Colombiana

    Nov 1, 2015, 00:00

  • The Impact Of New Endovascular Therapies For Femoropopliteal Arterial Disease On Therapy Utilization And Case Volumes In Germany, 2009-2013

    Nov 1, 2015, 00:00

  • A Novel Ibs Diagnostic Blood Panel Can Enhance A Positive Diagnostic Strategy Versus A Strategy Of Exclusion For Patients With Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)- Cost Implications For Denmark

    Nov 1, 2015, 00:00

  • Costo en Salud en la Intervencion de Atencion Integral de Personas Diagnosticadas Con Vih/Sida Para Reducir La Morbimortalidad Por Vih/Sida En El Perú, 2011-2014

    Nov 1, 2015, 00:00

  • Differences In Reimbursement Prices And Inequalities To Access Most Commonly Prescribed Medicines In Bosnia And Herzegovina

    Nov 1, 2015, 00:00

  • The Cumulative Analysis of Checklist Questionnaires Filled Out by the Hungarian HTA Office

    Nov 1, 2015, 00:00

  • How Good Are Physicians And Chart Reviews At Capturing Health Resources And Drug Utilisation By Patients? Results Of The Pgrx-3 Prospective Real World Dataset Validation Study

    Nov 1, 2015, 00:00

  • How Reducing The Equivalence Band Cap to Base Price For Selected 15 Groups impacts saving and Price Erosion in Turkey- Preliminary Results

    Nov 1, 2015, 00:00

  • Characteristics of Geriatric Patients Diagnosed With Multiple Sclerosis Taking Disease Modifying Agents In The United States

    Nov 1, 2015, 00:00

  • Using An Economic Model To Choose Initial Appropriate Antibiotic Therapy Based On Differences In In-Vitro Susceptibility To Ceftolozane/Tazobactam And Piperacillin/Tazobactam

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Cetuximab And Panitumumab For First Line Treatment Of Metastatic Colorectal Cancer (Mcrc) In Wt Ras Patients In Spain

    Nov 1, 2015, 00:00

  • Limitation of Benefit Assessments in Germany – Current Experience

    Nov 1, 2015, 00:00

  • The Burden of Illness of Congenital Adrenal Hyperplasia In The United Kingdom- A Retrospective, Observational Study

    Nov 1, 2015, 00:00

  • Transitioning From Generic To Protected Brand Drug In Patients With Dm, Hypertension And Hyperlipidemia

    Nov 1, 2015, 00:00

  • Análisis de Minimización de Costos de Tofacitinib en el Tratamiento de Pacientes Con Artritis Reumatoide Que Han Presentado Respuesta Inadecuada a Metotrexato en Colombia

    Nov 1, 2015, 00:00

  • Access to New Therapies in Romania Through the Scorecard HTA System

    Nov 1, 2015, 00:00

  • Use Of Xanthines In The Treatment Of Chronic Respiratory Diseases In Serbia, Compared With The Scandinavian Countries From 2004 To 2013

    Nov 1, 2015, 00:00

  • Quantifying The Cost And Quality Of Life Implications Of Adverse Events Associated With Long-Term Oral Corticosteroid Use

    Nov 1, 2015, 00:00

  • New Standards to Derive Preference-Based Hrqol Values

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Urothelial Transitional Cell Cancer Treatment with Vinflunine in Patients Resistant to the Platinum-Based Treatment Regimes

    Nov 1, 2015, 00:00

  • Access To Innovation And Economic Burden----A Case Of Non-Small Cell Lung Cancer In A Patient Access Program In Qingdao, China

    Nov 1, 2015, 00:00

  • Integrated Clinical Pathway in Schizophrenia

    Nov 1, 2015, 00:00

  • Conditional Copula Models With Applications to Biomarkers In Rheumatoid Arthritis

    Nov 1, 2015, 00:00

  • Diagnoses And Treatment Patterns For Non-Small Cell Lung Cancer (Nsclc) Within The Private Health System In Brazil

    Nov 1, 2015, 00:00

  • The Most Frequent Fears and Beliefs of 226 Patients with Rheumatoid Arthritis or Spondyloarthritis, Using a Novel Questionnaire

    Nov 1, 2015, 00:00

  • Co-Administration of Proton Pump Inhibitors in Chronic Aspirin Users and the Risk of Adverse Cardiovascular Events- a Population-Based Cohort Study

    Nov 1, 2015, 00:00

  • Economic Evaluation of Dasatynib In Treatment of Adult Patients With Philadelphia Chromosome Positive (Ph+) Acute Lymbphoblastic Leukemia (All) With Resistance or Intolerance to Prior Therapy In Poland

    Nov 1, 2015, 00:00

  • Potential Barriers to Insulin Intensification Among Patients With Type 2 Diabetes- The Patient Perspective In Germany

    Nov 1, 2015, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87 (current)
  • 88
  • 89
  • 90
  • »